BRCA database now holds data on 6200 variants
After one year of existence, the BRCA Share database has released details on its progress in collating information on variants of the BRCA1 and BRCA2 genes...
After one year of existence, the BRCA Share database has released details on its progress in collating information on variants of the BRCA1 and BRCA2 genes...
Myriad Genetics has been hit by a complaint filed by the American Civil Liberties Union (ACLU) on behalf of four patients who are seeking a right of access to all their genetic information held by the company...
by Rachel Siden
Adding more genes to existing multi-gene panels that test for breast and ovarian cancer risk offers little clinical benefit, a study says...
Women with a mutation in the breast-cancer susceptibility gene BRCA1 may have reduced numbers of eggs left in their ovaries, according to a study led by Australian scientists...
by Ryan Ross
Tania Simoncelli's narrates the story of the successful legal challenge against Myriad Genetics' BRCA patents, but may have missed an opportunity to consider the broader impact of gene patenting...
Genetic-testing company Ambry Genetics has launched a huge database of cancer-patient genetics, freely available to the public...
More than 95 percent of younger women diagnosed with early-onset breast cancer are opting for genetic testing, a study has found...
US start-up company Sure Genomics has launched the first whole-genome testing service available directly to consumers, for a cost of $2500...
Scientists have identified a mutation in the gene BRIP1 that triples a woman's risk of ovarian cancer...
by Chris Hardy
Scientists have identified a link between the product of the BRCA1 gene, variants which can cause breast and ovarian cancer, and Alzheimer's disease...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.